R. G. Menon

Irbesartan and Lipoic Acid Improve Endothelial Function and Reduce Markers of Inflammation in the Metabolic Syndrome: Results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) Study

F. Cheema, S. Parthasarathy, B. Khan, 2005, Circulation.

Chronic Iron Administration Increases Vascular Oxidative Stress and Accelerates Arterial Thrombosis

S. Rajagopalan, D. Duquaine, S. Day, 2003, Circulation.

Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome.

R. Natarajan, W. Hooper, S. Lerakis, 2004, Diabetes care.